Form 4 holding
Director
NRX Pharmaceuticals, Inc.
- Security class
- Common Stock
- Shares / value
- 43,093
- Estimated value
- $13,785
- Report date
- 24 May 2021
- Price
- $0.3199
- Ownership
- Direct
Daniel Troy
Insider Reports History
- Reporting-owner location
- Philadelphia, PA
- Latest reporting-owner signature
-
/s/ Daniel Troy
Source: Latest parsed Forms 3/4/5 signature
- Transaction source note
- Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.
Identity
Names, identifiers, and filing context for this profile.
1 identity field
SEC source record
Original filing metadata and source links for verification.
1 source field
Source evidence
Original filing metadata and source links for verification.
1 source field
Reported holdings for Daniel Troy
Form 4 holding
Director
NRX Pharmaceuticals, Inc.
- Security class
- Employee Stock Option (Right to buy)
- Shares / value
- 65,437
- Estimated value
- $13,087
- Report date
- 24 May 2021
- Price
- $0.2000
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Insider Reports Filed by Daniel Troy
4
NRXP
NRX Pharmaceuticals, Inc.
- Report period
- 24 May 2021
- Transactions
- 2
- Transaction value
- $0
- Accepted by SEC
- 10 Jun 2021, 18:48
- Role
- Director
- Next action
- Open filing details
3
NRXP
NRX Pharmaceuticals, Inc.
- Report period
- 24 May 2021
- Transactions
- 0
- Transaction value
- $0
- Accepted by SEC
- 10 Jun 2021, 18:33
- Role
- Director
- Next action
- Open filing details